Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
- Moleculin biotech Press release (Nasdaq:Mbrx): FY GAAP EPS – $ 6.32.
- As of December 31, 2024, the company had $ 4.3 million in cash and cash equivalent. The company believes that on February 31, 2025, the total funds and cash equivalents received on February 31, 2025 will be sufficient to finance $ 9.3 million for February 2025 financing.
